feed,title,long_url,short_url
Benzinga,Avidity Biosciences Shares Gain As Its Oligonucleotide Candidate Enters Early-Stage Trial In Muscle Wasting Disorder,https://benzinga.com/general/biotech/21/08/22277197/avidity-biosciences-shares-gain-as-its-oligonucleotide-candidate-enters-early-stage-trial-in-musc,https://j.mp/3ypwk4o
Benzinga,How Important Is Re-Investing Dividends? A Five-Year Analysis For John Bean Technologies,https://benzinga.com/news/earnings/21/08/22278050/how-important-is-re-investing-dividends-a-five-year-analysis-for-john-bean-technologies,https://j.mp/3ijmGuE
